Brandberg Yvonne, Johansson Hemming, Bergenmar Mia
Department of Oncology-Pathology, Karolinska Institutet Z1:00, Karolinska University Hospital, SE-17176 Stockholm, Sweden.
Department of Oncology, Karolinska University Hospital, SE-17176 Stockholm, Sweden.
Contemp Clin Trials Commun. 2015 Dec 17;2:6-11. doi: 10.1016/j.conctc.2015.12.001. eCollection 2016 Apr 15.
Recruitment to clinical trials is essential. The aims of the study were to investigate associations between patients' informed consent to participate in a cancer clinical trial and knowledge and perceived understanding of the trial. Furthermore, associations between demographic factors and consent to participate and knowledge and perceived understanding of information about the trial were studied.
The patients were recruited in connection to a visit at the oncology clinic for information about a drug trial. The Quality of Informed Consent questionnaire was mailed to the patients after they had decided about participation in the trial. The associations of demographic factors and "knowledge" and "perceived understanding" were analysed using linear regression models.
A total of 125 patients were included. Higher levels of "knowledge" and "understanding" were found to be associated with consent to participate in a clinical trial, both in the univariate and multivariate analyses (p = 0.001). None of the tested demographic factors were related to consent to participate. No statistically significant associations between any of the demographic factors and knowledge or perceived understanding scores were found.
The results indicate that interventions that increase patients' knowledge and perceived understanding might improve participation rates in clinical trials.
招募患者参与临床试验至关重要。本研究旨在调查患者参与癌症临床试验的知情同意与对试验的了解及感知理解之间的关联。此外,还研究了人口统计学因素与参与同意以及对试验信息的了解和感知理解之间的关联。
在肿瘤诊所就诊时招募患者以获取有关药物试验的信息。在患者决定参与试验后,将知情同意质量问卷邮寄给他们。使用线性回归模型分析人口统计学因素与“知识”和“感知理解”之间的关联。
共纳入125名患者。在单变量和多变量分析中,较高水平的“知识”和“理解”均与参与临床试验的同意相关(p = 0.001)。所测试的人口统计学因素均与参与同意无关。未发现任何人口统计学因素与知识或感知理解得分之间存在统计学显著关联。
结果表明,增加患者知识和感知理解的干预措施可能会提高临床试验的参与率。